CFB
NVO

Cullen/Frost Bankers’s Novo Nordisk NVO Stock Holding History

Cullen/Frost Bankers’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.4M Buy
341,905
+22,859
+7% +$982K 0.16% 124
2026
Q1 		$11.7M Buy
319,046
+151,624
+91% +$7.18M 0.13% 150
2025
Q4 		$8.52M Buy
167,422
+52,039
+45% +$2.66M 0.09% 178
2025
Q3 		$6.4M Sell
115,383
-2,506
-2% -$147K 0.07% 194
2025
Q2 		$8.14M Buy
117,889
+1,060
+0.9% +$72.1K 0.1% 173
2025
Q1 		$8.11M Buy
116,829
+1,387
+1% +$115K 0.11% 166
2024
Q4 		$9.93M Buy
115,442
+57
+0% +$6.16K 0.14% 148
2024
Q3 		$13.7M Buy
115,385
+380
+0.3% +$50.7K 0.19% 126
2024
Q2 		$16.4M Buy
115,005
+505
+0.4% +$66.9K 0.24% 102
2024
Q1 		$14.7M Sell
114,500
-14
-0% -$1.67K 0.22% 116
2023
Q4 		$11.8M Buy
114,514
+38
+0% +$3.76K 0.19% 131
2023
Q3 		$10.4M Sell
114,476
-3,418
-3% -$301K 0.18% 129
2023
Q2 		$9.54M Buy
117,894
+32,574
+38% +$2.66M 0.16% 144
2023
Q1 		$6.79M Buy
85,320
+298
+0.4% +$21.1K 0.12% 168
2022
Q4 		$5.75M Buy
85,022
+2,100
+3% +$123K 0.11% 177
2022
Q3 		$4.13M Sell
82,922
-70
-0.1% -$3.75K 0.09% 177
2022
Q2 		$4.62M Sell
82,992
-376
-0.5% -$20.9K 0.1% 175
2022
Q1 		$4.63M Sell
83,368
-388
-0.5% -$19.9K 0.09% 188
2021
Q4 		$4.69M Sell
83,756
-3,120
-4% -$169K 0.09% 195
2021
Q3 		$4.17M Sell
86,876
-3,742
-4% -$181K 0.08% 199
2021
Q2 		$3.8M Sell
90,618
-41,044
-31% -$1.59M 0.08% 202
2021
Q1 		$4.44M Buy
131,662
+4,882
+4% +$174K 0.1% 187
2020
Q4 		$4.43M Buy
126,780
+2,932
+2% +$101K 0.1% 175
2020
Q3 		$4.3M Buy
123,848
+6,714
+6% +$224K 0.11% 165
2020
Q2 		$3.83M Buy
117,134
+81,706
+231% +$2.61M 0.1% 176
2020
Q1 		$1.07M Buy
+35,428
New +$1.05M 0.04% 248
2019
Q4 		– Sell
-132
Closed -$3K – 1084
2019
Q3 		$3K Sell
132
-18
-12% -$455 ﹤0.01% 952
2019
Q2 		$4K Buy
150
+12
+9% +$297 ﹤0.01% 935
2019
Q1 		$4K Buy
+138
New +$3.39K ﹤0.01% 822

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

Cullen/Frost Bankers's NVO Position: Q2 2026 in Review

Cullen/Frost Bankers increased its Novo Nordisk (NVO) stake by 7.2% in Q2 2026, buying an estimated $982K and bringing the position to 341,905 shares worth $16.4M. The position accounts for 0.16% of the portfolio, ranked #124.

Cullen/Frost Bankers first reported a position in NVO in Q1 2019 and has held it in 29 quarters since. The position peaked at $16.4M in Q2 2024. 819 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Cullen/Frost Bankers held 341,905 shares of Novo Nordisk worth $16.4M as of Q2 2026.
  • Cullen/Frost Bankers bought 22,859 Novo Nordisk shares in Q2 2026, an estimated $982K.
  • Novo Nordisk made up 0.16% of Cullen/Frost Bankers's portfolio in Q2 2026, its #124 holding.
  • Cullen/Frost Bankers first reported a position in Novo Nordisk in Q1 2019 and has held it in 29 quarters since.
  • Cullen/Frost Bankers's Novo Nordisk position peaked at $16.4M in Q2 2024.
  • 819 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.